2021 Annual General Meeting
Date: Tuesday, March 2, 2021, 14:00 CET
Place: Novartis Campus, Basel, Switzerland
Important Information regarding COVID-19
Unfortunately, the situation regarding the coronavirus (COVID-19) did not allow us to hold the Annual General Meeting the conventional way.
On September 11, 2020, the Swiss Federal Council decided to extend the COVID-19 Ordinance 3 until December 31, 2021. In accordance with this ordinance, the Board of Directors of Novartis AG decided to hold the 2021 Annual General Meeting without shareholders being physically present. It was with great regret that the Board of Directors took this decision, but it considered this step as the only feasible option to protect the well-being of all parties involved. The safety of our shareholders and associates comes first.
Accordingly, shareholders could only exercise their shareholder rights via the Independent Proxy, lic. iur. Peter Andreas Zahn.
Agenda and Instructions
Invitation to the Annual General Meeting
(PDF 0.3 MB - including the brochure "Compensation Votes at the 2021 Annual General Meeting")
Sample of form "Appointment of Proxy and Instructions" for registered shareholders (PDF 0.9 MB)
Request to include an Agenda item (PDF 0.1 MB)
Media Release / Voting results / Minutes
Annual Report
Read the Annual Report 2020 or the Annual Review 2020
Virtual Speakers' Desk
The Virtual Speakers’ Desk was open from February 8 to 22, 2021. The Board of Directors addressed all submitted questions at the Annual General Meeting.